Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7295 USD | -4.01% | +16.29% | -47.89% |
Apr. 09 | Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT | CI |
Apr. 08 | Declaration of Voting Results by Seres Therapeutics | CI |
Financials (USD)
Sales 2024 * | 1.16M | Sales 2025 * | 7.64M | Capitalization | 110M |
---|---|---|---|---|---|
Net income 2024 * | -186M | Net income 2025 * | -153M | EV / Sales 2024 * | 238 x |
Net Debt 2024 * | 167M | Net Debt 2025 * | 243M | EV / Sales 2025 * | 46.2 x |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-0.91
x | Employees | 233 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on Seres Therapeutics, Inc.
1 day | -4.01% | ||
1 week | +16.29% | ||
Current month | -5.76% | ||
1 month | -5.11% | ||
3 months | -36.57% | ||
6 months | -52.48% | ||
Current year | -47.89% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Shaff
CEO | Chief Executive Officer | 48 | 14-10-31 |
David Ege
CTO | Chief Tech/Sci/R&D Officer | 50 | 20-10-21 |
Chief Tech/Sci/R&D Officer | - | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Ausiello
BRD | Director/Board Member | 78 | 15-03-31 |
Director/Board Member | 68 | 23-01-03 | |
Richard Kender
BRD | Director/Board Member | 68 | 14-10-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 237 M€ | +1.49% | - | |
0.02% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.7295 | -4.01% | 5,812,246 |
24-04-23 | 0.76 | +21.68% | 11,876,377 |
24-04-22 | 0.6246 | +11.56% | 4,223,862 |
24-04-19 | 0.5599 | -4.16% | 3,748,612 |
24-04-18 | 0.5842 | -6.87% | 3,788,552 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.89% | 110M | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.86% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- MCRB Stock